Click to cancel search
Login
Sign Up
Home Page
How It Works
Our Story
Symptom Checker
Second Opinion Finder
Newsroom
Partner With Us
MediFind Pro
FAQ
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
Submit Feedback
Advertising Policy
Privacy Policy
Terms & Conditions
Condition
Condition
Doctor
Symptom
Condition
Click to search for condition or expert
Login
Sign Up
Click to open main menu
Share
Share
Share
Click
Share
Share
Condition
Systemic Lupus Erythematosus
Symptoms, Doctors, Treatments, Research & More
Overview
Condition 101
Find a Doctor
Latest Research
Clinical Trials
Active Clinical Trials
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
450
Start Date:
August 12, 2020
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
280
Start Date:
August 7, 2020
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus
Clinical Trial
Behavioral
Status:
Recruiting
Study Type:
Behavioral
Participants:
75
Start Date:
August 4, 2020
A Remotely Delivered CBT Intervention for Youth With cSLE: A Multi-site Patient-engaged Investigation
Clinical Trial
Other
Status:
Recruiting
Participants:
5000
Start Date:
August 4, 2020
Rheumatology Patient Registry and Biorepository
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
250
Start Date:
July 30, 2020
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis (REGENCY)
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
260
Start Date:
July 27, 2020
A Phase 2, Long-Term Extension (LTE) Study With Elsubrutinib and Upadacitinib Given Alone or in Combination (ABBV-599) in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus Who Have Completed the M19-130 Phase 2 Randomized Controlled Trial (RCT)
Clinical Trial
Other
Status:
Recruiting
Study Type:
Other
Participants:
20
Start Date:
July 25, 2020
SLE Vasculitis Incidence In Female Egyptian Patients
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
110
Start Date:
July 15, 2020
A Multicenter, Randomized Controlled Clinical Study About Efficacy and Safety of Standard Dose and Individualized Dose of Rituximab in Maintaining Remission in Patients With Moderate to Severe Systemic Lupus Erythematosus
Clinical Trial
Device
Status:
Recruiting
Study Type:
Device
Participants:
34
Start Date:
July 15, 2020
Patient-reported Outcome Measures Collected in DANBIO Via a From Home Web Application Versus a Touchscreen in the Outpatient Clinic Among Patients With Systemic Lupus Erythematosus: A Randomised, Crossover, Agreement Study
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
460
Start Date:
July 7, 2020
A Two-year, Phase III Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Safety, Efficacy, and Tolerability of 300 mg s.c. Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis
Clinical Trial
Drug
Status:
Recruiting
Study Type:
Drug
Participants:
60
Start Date:
June 29, 2020
A Phase Ib/IIa Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerance, Pharmacokinetics/ Pharmacodynamics(PK/PD) of ICP-022 in Patients With Mild and Moderate Systemic Lupus Erythematosus
Clinical Trial
Diagnostic Test
Status:
Recruiting
Study Type:
Diagnostic Test
Participants:
200
Start Date:
June 1, 2020
Serologic Profile of SARS CoV2 in Patients With Systemic Diseases
